Diagnosis and management of multiple myeloma

Br J Haematol. 2001 Dec;115(3):522-40. doi: 10.1046/j.1365-2141.2001.03206.x.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Diphosphonates / therapeutic use
  • Drug Administration Schedule
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunotherapy / methods
  • Interferons / therapeutic use
  • Melphalan / therapeutic use
  • Multiple Myeloma / complications
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / therapy*
  • Oncology Service, Hospital
  • Patient Care Planning / standards
  • Patient Education as Topic
  • Patient Selection
  • Prednisolone / therapeutic use
  • Renal Insufficiency / complications
  • Renal Insufficiency / therapy

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Diphosphonates
  • Cyclophosphamide
  • Interferons
  • Prednisolone
  • Melphalan